Adjuvanted vs. Standard Flu Vaccine in People With HIV Over 50
Part of Infections, Lungs & breathing clinical trials.
This study compares two types of flu vaccines (one with an immune booster called an adjuvant, and one without) in people with HIV who are over 50. Researchers want to see which vaccine triggers a stronger immune response to better protect you from the flu.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years old or older and have HIV.
- Your most recent HIV viral load is under 330 (meaning the virus is well controlled).
- You have never had a serious allergic reaction to any flu vaccine.
- You do not have a severe bleeding disorder.
- You have not already gotten a flu shot for the 2025–2026 season.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new vaccine designed to help your immune system fight HIV better. It is for people with HIV who are already on effective antiretroviral therapy and have a well-controlled virus. The goal is to see if the vaccine is safe and boosts your body's natural defenses.
This study compares two different flu vaccines to see which one works better for people living with HIV. One vaccine uses a special ingredient called MF59 to boost immune response, while the other is a high-dose version. The goal is to understand which approach helps your body fight off the flu more effectively.
This trial tests whether a flu vaccine with an extra ingredient (called an adjuvant) is safer and works better for older Asian adults with chronic health conditions than a standard flu vaccine. It aims to provide better protection against the flu for people like you.
This trial studies how well your immune system responds to a vaccine in people who are younger adults or, especially, older adults and those with frailty. Your participation may help researchers understand why vaccine responses can differ with age.
This trial tests a new flu vaccine with an ingredient to boost your immune response. It's for adults who haven't had the flu or a flu shot in the past 6 months and are generally healthy.
This trial tests a new combination HIV vaccine in healthy adults to see if it is safe and produces an immune response. If you are at low risk for HIV, you may help researchers learn more about future prevention strategies.
Hear when a new Antibody Response trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.